# Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19

> **NCT04405492** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1210 (estimated)

## Conditions studied

- SARS-CoV 2
- COVID-19

## Interventions

- **DEVICE:** Taking blood samples (capillary and venous), saliva sampling and nasopharyngeal sampling.
- **DEVICE:** Taking blood samples (capillary and venous), saliva sampling and nasopharyngeal sampling.
- **DEVICE:** Capillary and salivary sampling

## Key facts

- **NCT ID:** NCT04405492
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-25
- **Primary completion:** 2021-03-25
- **Final completion:** 2021-03-25
- **Target enrollment:** 1210 (ESTIMATED)
- **Last updated:** 2020-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04405492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04405492, "Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04405492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*